SK pharmteco Announces CGMP Qualification of its Commercial-Scale Viral Vector Manufacturing Facility in France

RANCHO CORDOVA, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced the successful CGMP qualification of its manufacturing facility in Corbeil-Essonnes, France. This ...

Cell and Gene Therapy Manufacturing Market to Reach USD 146.2 Billion by 2032 Amid Rising Demand for Personalized Therapies, Viral Vector Capacity, and Automated Bioprocessing ...

The "Cell and Gene Therapy Manufacturing Market -- Growth, Share, Opportunities & Competitive Analysis, 2024 -- 2032" report has been added to the Credence Research Inc. offering. The global Cell and ...
Nasdaq

Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis

PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform technology ...
The Cincinnati Enquirer

Creative Biolabs: Advancing Gene Therapy with Cutting-Edge Viral Vector Analysis

Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing and quality control services. SHIRLEY, NY, UNITED ...
The Desert Sun

Creative Biolabs: Advancing Gene Therapy with Cutting-Edge Viral Vector Analysis

* Viral Vector Analysis Services Creative Biolabs provides a full range of viral vector analytical solutions with advanced equipment and technology, including AAV vector analysis, lentiviral vector ...

SK pharmteco Inc.: SK pharmteco Announces CGMP Qualification of its Commercial-Scale Viral Vector Manufacturing Facility in France

SK pharmteco today announced the successful CGMP qualification of its manufacturing facility in Corbeil-Essonnes, France. This state-of-the-art ...